FDA Adverse Event
Injury
Summary report: N
CENTRAL LINE
MDR report key: 13178728
·
Received January 5, 2022
Report
- Report Number
- MW5106510
- Event Type
- Injury
- Date Received
- January 5, 2022
- Date of Event
- January 2, 2022
- Report Date
- January 2, 2022
- Manufacturer
- UNK
- Product Code
- FOZ
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
SPONTANEOUS. SPOKE TO PHARMACIST AT HOSPITAL AND PROVIDED REMODULIN DOSING INFORMATION. PATIENT HAS BEEN ADMITTED DUE TO MALFUNCTION OF CENTRAL LINE. NO OTHER INFORMATION KNOWN. PRESCRIBER HAS BEEN NOTIFIED. PRESCRIBER REMS ID: (B)(6), PATIENT REMS ID: (B)(6). REPORTED TO (B)(6) BY HEALTH PROFESSIONAL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 792115 | CENTRAL LINE | CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS | FOZ | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 43 YR | Female | Hospitalization | REMODULIN |